Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Related financial report
ZVRA similar filings
- 31 May 22 Entry into a Material Definitive Agreement
- 16 May 22 KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline
- 12 May 22 KemPharm Reports First Quarter 2022 Financial Results and Corporate Updates
- 30 Mar 22 KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates
- 21 Mar 22 KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
- 16 Mar 22 KemPharm team provided development and regulatory services to Corium pursuant to a master development services agreement
- 22 Feb 22 Regulation FD Disclosure
Filing view
External links